Leiomyosarcoma risk factors: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 9: Line 9:
* Age: Leiomyosarcoma can be seen at 20 years of age but mean age at diagnosis is 50-60 years old.
* Age: Leiomyosarcoma can be seen at 20 years of age but mean age at diagnosis is 50-60 years old.
* Race:Black women have a higher incidence of development of the uterine leiomyosarcoma as compared to the white women.<ref name="pmid12050351">Wysowski DK, Honig SF, Beitz J (2002) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=12050351 Uterine sarcoma associated with tamoxifen use.] ''N Engl J Med'' 346 (23):1832-3. [http://dx.doi.org/10.1056/NEJM200206063462319 DOI:10.1056/NEJM200206063462319] PMID: [https://pubmed.gov/12050351 12050351]</ref>
* Race:Black women have a higher incidence of development of the uterine leiomyosarcoma as compared to the white women.<ref name="pmid12050351">Wysowski DK, Honig SF, Beitz J (2002) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=12050351 Uterine sarcoma associated with tamoxifen use.] ''N Engl J Med'' 346 (23):1832-3. [http://dx.doi.org/10.1056/NEJM200206063462319 DOI:10.1056/NEJM200206063462319] PMID: [https://pubmed.gov/12050351 12050351]</ref>
* Long term use of the tamoxifen: Prolonged use of the tamoxifen esp more than five years has been associated with the increased risk of development of leiomyosarcoma.<ref name="pmid11336777">Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11336777 Tamoxifen treatment and gynecologic side effects: a review.] ''Obstet Gynecol'' 97 (5 Pt 2):855-66. PMID: [https://pubmed.gov/11336777 11336777]</ref>
* Long term use of the [[tamoxifen]]: Prolonged use of the tamoxifen esp more than five years has been associated with the increased risk of development of leiomyosarcoma.<ref name="pmid11336777">Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11336777 Tamoxifen treatment and gynecologic side effects: a review.] ''Obstet Gynecol'' 97 (5 Pt 2):855-66. PMID: [https://pubmed.gov/11336777 11336777]</ref>
* History of Pelvic radiations:Pelvic irradiation has been associated with the increased development of the leiomyosarcoma.<ref name="pmid15168177">Fang Z, Matsumoto S, Ae K, Kawaguchi N, Yoshikawa H, Ueda T et al. (2004) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15168177 Postradiation soft tissue sarcoma: a multiinstitutional analysis of 14 cases in Japan.] ''J Orthop Sci'' 9 (3):242-6. [http://dx.doi.org/10.1007/s00776-004-0768-5 DOI:10.1007/s00776-004-0768-5] PMID: [https://pubmed.gov/15168177 15168177]</ref><ref name="pmid25315801">Futuri S, Donohoe K, Spaccavento C, Yudelman I (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25315801 Rectal leiomyosarcoma: a rare and long-term complication of radiation therapy.] ''BMJ Case Rep'' 2014 ():. [http://dx.doi.org/10.1136/bcr-2014-205240 DOI:10.1136/bcr-2014-205240] PMID: [https://pubmed.gov/25315801 25315801]</ref>
* History of Pelvic radiations:Pelvic irradiation has been associated with the increased development of the leiomyosarcoma.<ref name="pmid15168177">Fang Z, Matsumoto S, Ae K, Kawaguchi N, Yoshikawa H, Ueda T et al. (2004) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15168177 Postradiation soft tissue sarcoma: a multiinstitutional analysis of 14 cases in Japan.] ''J Orthop Sci'' 9 (3):242-6. [http://dx.doi.org/10.1007/s00776-004-0768-5 DOI:10.1007/s00776-004-0768-5] PMID: [https://pubmed.gov/15168177 15168177]</ref><ref name="pmid25315801">Futuri S, Donohoe K, Spaccavento C, Yudelman I (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25315801 Rectal leiomyosarcoma: a rare and long-term complication of radiation therapy.] ''BMJ Case Rep'' 2014 ():. [http://dx.doi.org/10.1136/bcr-2014-205240 DOI:10.1136/bcr-2014-205240] PMID: [https://pubmed.gov/25315801 25315801]</ref>
* Certain Hereditary condition like Gardner syndrome, Li-Fraumeni syndrome,Werner syndrome and Neurofibromatosis are associated with the development of leiomyosarcoma.
* Certain Hereditary condition like [[Gardner's syndrome|Gardner syndrome]], [[Li-Fraumeni syndrome]],[[Werner syndrome]] and [[Neurofibromatosis]] are associated with the development of leiomyosarcoma.
* Long term survivors of the Retinoblastoma are at higher risk of developing variety of soft tissue sarcoma.<ref name="pmid19351917">Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M et al. (2009) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19351917 Cause-specific mortality in long-term survivors of retinoblastoma.] ''J Natl Cancer Inst'' 101 (8):581-91. [http://dx.doi.org/10.1093/jnci/djp046 DOI:10.1093/jnci/djp046] PMID: [https://pubmed.gov/19351917 19351917]</ref>
* Long term survivors of the [[Retinoblastoma]] are at higher risk of developing variety of soft tissue sarcoma.<ref name="pmid19351917">Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M et al. (2009) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19351917 Cause-specific mortality in long-term survivors of retinoblastoma.] ''J Natl Cancer Inst'' 101 (8):581-91. [http://dx.doi.org/10.1093/jnci/djp046 DOI:10.1093/jnci/djp046] PMID: [https://pubmed.gov/19351917 19351917]</ref>


==References==
==References==

Revision as of 18:58, 5 July 2018

Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma risk factors

CDC on Leiomyosarcoma risk factors

Leiomyosarcoma risk factors in the news

Blogs on Leiomyosarcoma risk factors

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Risk Factors

Clinical data has suggested that the development of leiomyosarcoma is related to radiation exposure. Other causes are not known for certain.

Following Risk Fcators found to be associated with the development of the Uterine leiomyosarcoma:

  • Age: Leiomyosarcoma can be seen at 20 years of age but mean age at diagnosis is 50-60 years old.
  • Race:Black women have a higher incidence of development of the uterine leiomyosarcoma as compared to the white women.[1]
  • Long term use of the tamoxifen: Prolonged use of the tamoxifen esp more than five years has been associated with the increased risk of development of leiomyosarcoma.[2]
  • History of Pelvic radiations:Pelvic irradiation has been associated with the increased development of the leiomyosarcoma.[3][4]
  • Certain Hereditary condition like Gardner syndrome, Li-Fraumeni syndrome,Werner syndrome and Neurofibromatosis are associated with the development of leiomyosarcoma.
  • Long term survivors of the Retinoblastoma are at higher risk of developing variety of soft tissue sarcoma.[5]

References

  1. ↑ Wysowski DK, Honig SF, Beitz J (2002) Uterine sarcoma associated with tamoxifen use. N Engl J Med 346 (23):1832-3. DOI:10.1056/NEJM200206063462319 PMID: 12050351
  2. ↑ Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97 (5 Pt 2):855-66. PMID: 11336777
  3. ↑ Fang Z, Matsumoto S, Ae K, Kawaguchi N, Yoshikawa H, Ueda T et al. (2004) Postradiation soft tissue sarcoma: a multiinstitutional analysis of 14 cases in Japan. J Orthop Sci 9 (3):242-6. DOI:10.1007/s00776-004-0768-5 PMID: 15168177
  4. ↑ Futuri S, Donohoe K, Spaccavento C, Yudelman I (2014) Rectal leiomyosarcoma: a rare and long-term complication of radiation therapy. BMJ Case Rep 2014 ():. DOI:10.1136/bcr-2014-205240 PMID: 25315801
  5. ↑ Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M et al. (2009) Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst 101 (8):581-91. DOI:10.1093/jnci/djp046 PMID: 19351917


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Leiomyosarcoma_risk_factors&oldid=1481000"